Introduction
Obstructive sleep apnea syndrome (OSAS) is a prevalent disease among adults and children, 2-4% [1] and 1-4%, respectively. Further, a recent epidemiological review based on questionnaires suggests that the prevalence of parent-reported symptoms of pediatric sleepdisordered breathing (SDB) is 4-11% [2] .
OSA (Obstructive sleep apnea) is characterized by prolonged partial upper airway obstruction, intermittent complete or partial obstruction or both prolonged and intermittent obstruction that disrupts normal ventilation during sleep, normal sleep patterns or both [3, 4] .
OSAS also includes daytime symptoms. SDB is a wider concept with a spectrum of symptoms in which the milder forms comprise primary snoring and mouth breathing, often caused by nasal congestion and/or adenoid hypertrophy. The more severe forms of SDB comprise symptoms similar to the more strictly defined entity, pediatric OSAS, i.e., intermittent breathing pauses (apneas), snorts or gasps, and disturbed sleep. In younger children, the most common risk factor for the more severe form of SDB and OSAS is adenotonsillar hypertrophy [5] , and surgical removal of adenoids and tonsils is the first treatment option. The complications of pediatric OSAS and SDB have in several studies shown to be similar; daytime neurobehavioral problems with impaired school performance and hypertension [6, 7] .
Previous epidemiologic studies on familial associations have indicated that genetic factors might constitute a risk factor for OSAS and SDB. In Sweden, the construction of large population-based patient registers led to a previous study by our group which showed, after accounting for socioeconomic status, age, geographic region, and period of diagnosis, an increased sibling risk of OSAS and SDB caused by adenotonsillar hypertrophy in children [8] .
Understanding the familial risk of OSAS and or SDB will help clinicians to identify children at risk and offer opportunities for early intervention and treatment.
The present study represents a novel contribution, i.e., investigating the relationship between OSAS and or SDB with adenotonsillar or tonsillar hypertrophy, in children with parental OSAS.
The aim of this study was to estimate the risk of hospitalization during an 11-year period for pediatric OSAS and or SDB in the offspring of parents with a hospital diagnosis of OSAS.
This risk was compared with that of offspring without parental OSAS. A further aim was to determine whether there were any differences by age or gender.
Material and Method

Outcome variables:
The total number of subjects and the incidence rate of hospital diagnosis of adult and pediatric OSAS, as well as pediatric adenotonsillar or tonsillar hypertrophy, were calculated for different age-groups, gender, period of diagnosis, region of residence and family income.
Further, the standardized incidence ratios (SIRs, see below) of the pediatric diagnoses were calculated in offspring with a parent hospitalized for OSAS and compared with offspring to parents without hospitalization for OSAS.
Sweden has a social welfare system that comprises public primary and hospital health care for all individuals with a residence permit. To diagnose OSAS, sleep studies are required, i.e., full-night polysomnography (PSG), which represents a Golden standard. However, PSG is time-consuming, expensive, and not widely available in all countries. In Sweden, PSG is available but ambulant sleep apnea recordings or polygraphy (PG) is more widely used. It has been validated against PSG [9] . Sweden follows the definitions of OSAS according to the American Academy of Sleep Medicine; i.e., an Apnea Hypopnea Index (AHI) of at least 5 is required in adults. There are no strictly defined criteria of OSAS in children. However, it has been proposed to represent an apnea-hypopnea index of more than 1 per sleep hour [4] [10] .
Fewer children than adults with symptoms of OSAS undergo sleep studies in Sweden; the ICD codes included below could therefore represent SDB in the children. Since SDB has no special diagnostic code, hospitalized children with such symptoms and suspected OSAS often The ICD-10 code of OSAS, G47.3, was also used in the parents.
Diagnostic codes at the individual level were retrieved from the Swedish Hospital Discharge
Register in the MigMed2 database.
MigMed Research Database
Data used in this study were retrieved from the MigMed2 database, located at the Center for Primary Health Care Research, Lund University, Sweden. MigMed is a single, comprehensive database that has been constructed using several national Swedish data registers, including but not limited to, the Population Register, the Multigeneration Register, and the Swedish Hospital Discharge Register (1986-2007) [11] [12] [13] . Information from the various registers in the database was linked at the individual level via the national 10-digit civic registration number assigned to each person in Sweden for his or her lifetime. Prior to inclusion in the MigMed database, civic registration numbers were replaced by serial numbers to ensure the anonymity of each individual.
Since the database contains information from the Multigeneration register, it is possible to link more than 7.6 million index persons (person born in or after 1932 and registered in Sweden any time since 1961) with their biological parents, children, and siblings.
Explanatory Variables
Explanatory variables included gender, age at first hospital diagnosis of the outcome variable, socioeconomic status (defined as family income), and geographic region of residence (i.e., in most cases geographic region of hospitalization). Family income was divided into four categories based on the income level recorded by the taxation authorities.
Family income was provided by Statistics Sweden and was defined as the family income
during the year of childbirth divided by the number of people in the mother's family. The income parameter also took into consideration the ages of people in the family and used a weighted system whereby small children were given lower weights than adolescents and adults.
Geographic region was divided into large cities (cities with a population of more than 200,000
i.e., Stockholm, Gothenburg, and Malmö), Southern Sweden, and Northern Sweden.
Geographic region was included as an explanatory variable to adjust for possible differences between geographic regions in Sweden with regard to hospital admission for the different outcome variables.
Statistical Analysis
Using the individual-level data in the MigMed2 database, the entire pediatric population of Sweden was sorted into families based on a shared mother and father. The database was then used to determine the presence or absence of a primary hospital diagnosis of pediatric OSAS or hypertrophy of the tonsils, or hypertrophy of the adenoids and tonsils, in each individual aged ≤18 years (the offspring) during the follow-up period. Next, the offspring was categorized as positive or negative for parental OSAS based on the presence or absence of the disorder in the mother and/or father. Offspring with diagnoses of OSAS and or adenotonsillar hypertrophy but without maternal and/or paternal hospitalization for OSAS was the reference group. The individual serial numbers described in the section on the MigMed2 research database were used to check that those with hospital diagnoses of pediatric OSAS, or hypertrophy of the tonsils, or hypertrophy of the adenoids and tonsils, appeared only once in the dataset, i.e., for their first hospital diagnosis during the study period.
Person-years were calculated from the start of the follow-up on January 1, 1997, to hospitalization for OSAS, or hypertrophy of the tonsils, or hypertrophy of the adenoids and tonsils, death, emigration, or the end of the study on December 31, 2007. Age-specific incidence rates (defined as first hospitalization rates during the study period) were calculated for the whole follow-up period. The results are shown as standardized incidence ratios (SIRs) with 95% confidence intervals (CIs). SIRs were calculated as the ratio of the observed (No) to the expected number of cases. The expected number of cases was calculated for age, gender, time period, region, and socioeconomic status-specific standard incidence rates derived from offspring lacking an affected parent. The test statistic 2 was used to calculate the probability (P value) of the SIR ratio between sons and daughters.
Ethical Considerations
This study was approved by the Ethics Committee of Lund University, Sweden.
Results
Descriptive characteristics of the study population and their parents
There were 34 933 children with diagnoses of OSAS and/or adenotonsillar or tonsillar hypertrophy and 23 413 parents with OSAS diagnoses during the study period (Table 1) .
Among the diagnosed children, 5.7 % had a first hospital diagnosis of OSAS. The majority of the children were 4-7 years old and 54.1 % were boys. The most common age at diagnoses among the parents was 50-59 years.
Pediatric OSAS and adenotonsillar or tonsillar hypertrophy was most common among families with low and middle low income, 42.5% and 34.9 %, respectively.
There were 153 children (7.6%) diagnosed with OSAS who were also diagnosed with adenotonsillar or tonsillar hypertrophy. There were no families with both parents affected by OSAS.
Gender and age-specific incidence rate of pediatric OSAS
Of the entire population (Table 2) , a total of 1 167 sons and 841 daughters aged 0-18 years had a diagnosis of OSAS during the study period. The hospitalization rate was 10.5 per 100 000 person-years for sons, and 8.0 for daughters (p < 0.001), a significant gender difference.
For those children with a parent affected with OSAS, the incidence rate for sons with OSAS was 26.1 per 100 000 person-years, and for daughters, 29.4, a non-significant gender difference.
Gender and age-specific incidence rate of adenotonsillar or tonsillar hypertrophy
Of the entire population ( For those children with a parent affected with OSAS, the incidence rate for sons with adenotonsillar or tonsillar hypertrophy was 219.0 per 100 000 person-years and, for daughters, 190.3, a non-significant gender difference.
The hospitalization rate for pediatric OSAS as well as adenotonsillar or tonsillar hypertrophy was significantly higher for offspring with parental OSAS compared to those without parental OSAS, among children below 8 years ( Figures A and B) .
Standardized incidence ratios (SIR) of pediatric OSAS and adenotonsillar or tonsillar hypertrophy
The overall SIR of pediatric OSAS among those with parental OSAS was 3.09 (95% CI, 1.83- 
4.90) in sons (
Discussion:
The main finding of this study was that offspring with parental OSAS had a substantially higher risk of hospitalization for SDB, defined as pediatric OSAS or adenotonsillar or tonsillar hypertrophy than offspring without parental OSAS. The standardized incidence ratio was highest in the group with pediatric OSAS; 3.09 in sons and 4.46 in daughters.
Additionally, a large number of children with adenotonsillar or tonsillar hypertrophy, one of the main etiologic factors for pediatric SDB and OSAS in young children, were included. The standardized incidence ratio was 1.82 in sons and 1.56 in daughters, i.e., lower than for OSAS, but still significantly increased. The present study has a novel approach to investigate familial aggregation; the use of hospital diagnosis, and the investigation of individual correlations between pediatric SDB and parental OSAS.
There were significant gender differences in the incidence rates of pediatric OSAS as well as adenotonsillar or tonsillar hypertrophy in the entire study population, with a higher rate in sons than in daughters. This is in accord with previous studies, which have shown that boys have a higher frequency of SDB than girls [2] . There were no significant gender differences in the incidence rates of these diagnoses in offspring with a parent affected with OSAS, which can be explained by the relatively fewer numbers of patients in this subgroup than in the entire population The categorization into different age groups in the present study showed that the highest incidence of SDB is in the group below 8 years. Other studies have shown similar results with a higher frequency of SDB in younger children [14] . In the present study, family income was investigated as an indicator of socioeconomic position. Pediatric OSAS and adenotonsillar or tonsillar hypertrophy was most common among families with low or middle low income, 42.5% or 34.9 %, respectively. Canadian studies have also shown a correlation between socioeconomic status and pediatric SDB [15] .
The association between pediatric and parental SDB/OSAS is in accord with an earlier study by Kalra et al. [16] , who found a significant association between children and parents with habitual snoring. Previous epidemiologic studies conducted in different adult populations have also demonstrated familial aggregations of OSA [17, 18] . The prevalence has varied quite a lot, from 21% in the Cleveland Family Study [18] to 84% in a Californian sample [19] among first-degree relatives of probands with OSAS. The Cleveland Study also reported that a person with a first-degree relative with OSAS has a 50% higher risk of having OSAS than an individual with no affected relatives [18] . Another study in Iceland reported a twofold risk in first-degree relatives [20] . Studies also including control samples showed that the odds ratio (OR) ranged from 2 to 46 [17, 18, 19] . It has been estimated that approximately 40% of the variance of the apnea-hypopnea index may be explained by familial factors [21] .
Heredity might be an explanation for the increased familial risk as indicated by studies of adults and children [22] . Twin studies have shown a higher concordance for snoring between monozygotic twins than between dizygotic [23] . The genetics of OSA is probably multifactorial. One of the factors is ethnicity, as the prevalence of SDB is higher among Afro-Americans [2] . Another factor is obesity, which is the most important risk factor for OSAS in adults. In children in Western countries, overweight and obesity are growing health problems.
Obesity is considered to be inherited in a multi-factorial way [24] . Dayyat et al. suggest that OSA in obese children is a phenotypic variant of OSA closely resembling that in adults [25] .
The authors also divide pediatric OSA into type I and type II. Type I is associated with marked lymphadenoid hypertrophy and an absence of obesity and is seen primarily in the youngest children, and type II with obesity and an absence of lymphadenoid hypertrophy, resembling adult OSAS, and is seen primarily in older children.
Further, adenotonsillar or tonsillar hypertrophy might be inherited, and the size of the tonsils and adenoids increases from birth to adolescence with the greatest increase during the first years of life [26] . In a recent study by Khalyfa et al. [27] , palatine tonsils in children were analyzed regarding gene expression to identify putative mechanistic pathways associated with tonsillar proliferation and hypertrophy in OSA. The authors found that phosphoserine phosphatase in tonsillar tissue played a role in hypertrophy in OSA children, but not in that derived from children with recurrent tonsillitis.
An additional genetic factor is facial growth and upper airway soft tissue (i.e., nasal obstruction). Bixler et al. have published data from the largest population-based sleep cohort, performed in American children aged 5-12. The authors concluded that, besides excess weight, nasal abnormalities (and not tonsil size) were statistically significant predictors of SDB in this age group [28] . Inflammation is also considered to be an important genetic factor, as inflammatory markers were up regulated in RNA studies of peripheral leukocytes in children with OSAS, which was not found in non-OSAS children [29] .
A further explanation of our findings is the increased medical awareness of SDB over time among both caregivers and the general population. The environment may also be a risk factor for SDB, e.g., parental smoking and low maternal education [30] .
The present study has some weaknesses; only a few children undergo polysomnography or other objective sleep studies in Sweden; the diagnoses of OSAS in the children are therefore most often clinical. However, the use of hospitalization data suggests that we have included children with more severe symptoms of SDB and suspected OSAS, as children with milder forms more often undergo surgery without hospitalization. In addition, most children in our study population were not diagnosed with OSAS; only 5.7% had this diagnosis whereas 94.3% had adenotonsillar or tonsillar hypertrophy without infection.
The use of hospital data suggests that we may also have included adult patients with a more 
Conclusion
The study indicates a familial clustering of sleep-disordered breathing, findings that are useful for health professionals. Future studies could examine the possible interactions between hereditary and environmental factors. Table 4 . Standardized incidence ratios and observed number of cases of obstructive sleep apnea syndrome (OSAS), hypertrophy of tonsils or hypertrophy of adenoids and tonsils in daughters, showed by age groups
